UAEM - Licensing and patenting practices of UK research institutions 2019-2020

Sarai Keestra made this Freedom of Information request to University of Reading

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

The request was successful.

Dear University of Reading,

We have previously sent FOI requests asking for information about the licensing practices of UK universities. This was concerning the time period 18th October 2018 to 18th October 2019. We are now looking to update the information for the following year, 19th October 2019 to 19th October 2020.

The updated request is listed below:

For the purpose of clarity, please adhere to the following definitions when answering these questions:

Definitions
Low and middle income country: A country that is defined as ‘low’, ‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year 2018. Income status defined by GNI per capita.
Source: World bank, available online [https://tinyurl.com/y5dwc2qv]

A patent grants an inventor the exclusive rights to his or her invention. A patent holder can stop other people from selling, manufacturing, producing, or using the invention for a certain period of time.
Source: Upcouncil, available online [https://www.upcounsel.com/what-is-a-pate...

Licence: Permission for the licensee to use the intellectual property rights
Source: TaylorWessing, available online [https://www.taylorwessing.com/download/a...

Exclusive Licence: A licence that allows only the named licensee to exploit the relevant IP rights, the licensor is also excluded from exploiting these IP rights.

Non-Exclusive Licence: A licence that grants any number of licensees to exploit the IP.
Source: TaylorWessing, available online [https://www.taylorwessing.com/synapse/co...

Health Technology: ‘Health technology as defined by the WHO: “A health technology is the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of lives.’
Source: WHO, available online [https://www.who.int/health-technology-as...

START FOI request:
Q1. Has the university committed to licensing its medical discoveries in ways that promote access and affordability in Low- and Middle- Income Countries? If yes, please provide a link or PDF to the relevant policy document.

Q2. Please provide an Excel spreadsheet with headings as displayed below with all the health technologies LICENSED by the university in the period 19th October 2019 to 19th October 2020 AND specify which countries they were licensed in AND specify whether they are exclusive or non-exclusive licenses.
Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-Exclusive)

Q3. Please provide a list of patents granted to your organization in the period 19th October 2019 to 19th October 2020, listed by patent family, indicating countries/regions in which the patent has been granted.

Q4. In the period 19th October 2019 to 19th October 2020, has the university shared its best practices for promoting access to medicines through non-exclusive licensing by carrying out any of the following activities?

❏ Contributed sample clauses to the AUTM Global Health Toolkit
❏ Published an article, guidance, or other literature on access licensing practices
❏ Formally presented on access licensing practices at an academic or professional event, or at another university
❏ Informally shared or discussed access licensing practices with administrators at other universities
❏ Other
❏ None
(Tick as appropriate)

Q5. What actions has the technology transfer office (TTO) undertaken in the period 19th October 2019 to 19th October 2020 to improve access to the technologies they license in low-and middle-income settings?

END FOI request.
If you have any questions please do not hesitate to contact me by email.

Yours faithfully,

Sarai Keestra

IMPS, University of Reading

Dear Ms Keestra,

This is to acknowledge receipt of your request for information below and to let you know it is being processed.

We'll get back to you as soon as we can, but in any case within 20 working days from 31/10/2020.

In the meantime, if you wish to add any further details or check on progress, please reply to this message, quoting 'IMPS#02928', so that we can track your input and respond promptly.

Yours sincerely,

Sinead Latham
Information Management & Policy Services (IMPS), University of Reading, Whiteknights, Reading, RG6 6AH
t: +44 (0)118 378 8981 www.reading.ac.uk/foia

show quoted sections

IMPS, University of Reading

Dear Ms Keestra, 

 

We have completed the compilation of information in response to your
request.

 

We can confirm that we do hold some information of the description
specified in your request. Our responses are given below each limb of your
request below.

 

**************** FOI RESPONSE *****************

Q1. Has the university committed to licensing its medical discoveries in
ways that promote access and affordability in Low- and Middle- Income
Countries? If yes, please provide a link or PDF to the relevant policy
document.

 

Since the University is a charitable organisation, where research has been
carried out with public funding it seeks to disseminate research into the
wider community in manner which is in line with the funder terms and
conditions, but mostly through publication and generally would not seek IP
protection. If the University were to seek IP protection, the University
would not file patent applications in countries which are in the low-
middle income category.

 

Should the opportunity arise whereby a medical discovery is made, the
University would seek to work with relevant third parties that would be in
the best position to provide access to the medical innovation. Whilst the
University would make every effort to work with companies that are
committed to providing accessible medical technologies, it is not able to
guarantee that the partners would in fact deliver.

 

The University does not have a specific policy covering access to medical
discoveries or licensing of IP in general to promote access and
affordability. The University does however, have Code of Practice policy
which states the aims of the University, particularly in terms of
dissemination of research findings, which in the main will be through
publication.

 

[1]http://www.reading.ac.uk/web/files/reas/...

Q2. Please provide an Excel spreadsheet with headings as displayed below
with all the health technologies LICENSED by the university in the period
19th October 2019 to 19th October 2020 AND specify which countries they
were licensed in AND specify whether they are exclusive or non-exclusive
licenses.

 

Health Technology Licensed | Country of Licensing | Type of License
(Exclusive or Non-Exclusive)

 

No health technologies have been licensed by the University in the year
19th October 2019 to 19th October 2020

Q3. Please provide a list of patents granted to your organization in the
period 19th October 2019 to 19th October 2020, listed by patent family,
indicating countries/regions in which the patent has been granted.

 

No health technology patents have been granted in the year 19th October
2019 to 19th October 2020.

Q4. In the period 19th October 2019 to 19th October 2020, has the
university shared its best practices for promoting access to medicines
through non-exclusive licensing by carrying out any of the following
activities?

 

❏ None

(Tick as appropriate)

 

Q5. What actions has the technology transfer office (TTO) undertaken in
the period 19th October 2019 to 19th October 2020 to improve access to the
technologies they license in low-and middle-income settings?

 

None

 

**********************************************

  

We are required to include details of our complaints procedures, including
your rights to apply to the Information Commissioner.  The procedure is
detailed in our Freedom of Information and Environmental Information
Regulations policy on the web at
[2]www.reading.ac.uk/freedom-of-information-policy

 

If we are unable to resolve any complaint, you can complain to the
Information Commissioner, the independent body who oversees the access to
information regimes: [3]https://ico.org.uk/make-a-complaint/ 

 

 

Yours sincerely, 

 

Sinead Latham

Information Compliance Officer

 

Information Management & Policy Services (IMPS), University of Reading,
Whiteknights, Reading, RG6 6AH

[4][University of Reading request email]    t: +44 (0)118 378 8981   
[5]www.reading.ac.uk/foia

show quoted sections